≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Other and unspecified immunodeficiencies with predominantly antibody defects

DOID MESH PheWeb

D3_IMMUDEFANTIBODYNAS

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D80.8, D80.9
Hospital discharge: ICD-9 2790C|2790X
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D80.8, D80.9
Cause of death: ICD-9 2790C|2790X
Cause of death: ICD-8 $!$

314

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

314

diagram downward connector

Check minimum number of events None

314

diagram downward connector

Include endpoints None

314

diagram downward connector
D3_IMMUDEFANTIBODYNAS

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 314 207 107
Unadjusted prevalence (%) 0.09 0.10 0.07
Mean age at first event (years) 47.31 48.41 45.18

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.53 [1.09, 11.39] 3.5e-2 26
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: D3_IMMUDEFANTIBODYNAS – Other and unspecified immunodeficiencies with predominantly antibody defects
GWS hits:

Survival analyses between endpoints

↥

Plot

before Other and unspecified immunodeficiencies with predominantly antibody defects
after Other and unspecified immunodeficiencies with predominantly antibody defects

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other and unspecified immunodeficiencies with predominantly antibody defects

↥